Goykhman Yaacov, Ben-Haim Menahem, Rosen Galia, Carmiel-Haggai Michal, Oren Ran, Nakache Richard, Szold Oded, Klausner Joseph, Kori Isaac
Department of Surgery B, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Isr Med Assoc J. 2010 Nov;12(11):687-91.
Inserting a transjugular intrahepatic portosystemic shunt by means of interventional radiology has become the procedure of choice for decompression of portal hypertension. The indications and criteria for patient selection have been expanded and refined accordingly.
To review our experience with TIPS and analyze the results with emphasis on patient selection and indication (conventional vs. atypical).
In this retrospective analysis in a single center all cases were managed by a multidisciplinary team (comprising liver surgery and transplantation, hepatology, imaging, interventional radiology and intensive care).
Between August 2003 and December 2009, 34 patients (mean age 51, range 27-76 years) were treated with TIPS. The cause of portal hypertension was cirrhosis (23 cases), hypercoagulability complicated by Budd-Chiari syndrome (n=6), and acute portal vein thrombosis (n=5). Clinical indications for TIPS included treatment or secondary prevention of variceal bleeding (10 cases), refractory ascites (n=18), mesenteric ischemia due to acute portal vein thrombosis (n=5), and acute liver failure (n=1). TIPS was urgent in 18 cases (53%) and elective in 16. Three deaths occurred following urgent TIPS. The overall related complication rate was 32%: trasient encephalopathy (6 cases), ischemic hepatitis (n=2), acute renal failure (n=2) and bleeding (n=1). Long-term results of TIPS were defined as good in 25 cases (73%), fair in 4 (12%) and failure in 5 (15%). In three of five patients with mesenteric ischemia following acute portal vein thrombosis, surgery was obviated. Revision of TIPS due to stenosis or thrombosis was needed in 7 cases (20%).
TIPS is safe and effective. While its benefit for patients with portal hypertension is clear, the role of TIPS in treatment of portal-mesenteric venous thrombosis needs further evaluation. Patient selection, establishing the indication and performing TIPS should be done by a multidisciplinary dedicated team.
通过介入放射学方法插入经颈静脉肝内门体分流术(TIPS)已成为门静脉高压减压的首选治疗方法。相应地,患者选择的适应证和标准也得到了扩展和完善。
回顾我们应用TIPS的经验,并着重分析患者选择和适应证(传统与非典型)的结果。
在本单中心回顾性分析中,所有病例均由多学科团队(包括肝脏外科与移植、肝病学、影像学、介入放射学和重症监护)进行管理。
2003年8月至2009年12月期间,34例患者(平均年龄51岁,范围27 - 76岁)接受了TIPS治疗。门静脉高压的病因包括肝硬化(23例)、高凝状态合并布加综合征(n = 6)和急性门静脉血栓形成(n = 5)。TIPS的临床适应证包括治疗或二级预防静脉曲张出血(10例)、难治性腹水(n = 18)、急性门静脉血栓形成导致的肠系膜缺血(n = 5)和急性肝衰竭(n = 1)。18例(53%)TIPS为急诊手术,16例为择期手术。急诊TIPS术后有3例死亡。总体相关并发症发生率为32%:短暂性脑病(6例)、缺血性肝炎(n = 2)、急性肾衰竭(n = 2)和出血(n = 1)。TIPS的长期效果定义为良好25例(73%)、中等4例(12%)和失败5例(15%)。在5例急性门静脉血栓形成后发生肠系膜缺血的患者中,有3例避免了手术。7例(20%)因狭窄或血栓形成需要对TIPS进行修正。
TIPS安全有效。虽然其对门静脉高压患者的益处明确,但TIPS在门静脉 - 肠系膜静脉血栓形成治疗中的作用需要进一步评估。患者选择、确定适应证和实施TIPS应由多学科专业团队进行。